Hanmi Pharmaceutical Stocks Target Price Raised to 650,000 Won on AI Drug Deal
iM Securities raised its target price for Hanmi Pharmaceutical to 650,000 won from 600,000 won on October 8, reflecting the value of an obesity drug candidate designed using the company's artificial intelligence platform and anticipated large upfront payments. The brokerage maintained its 'buy'
Hanmi Pharmaceutical+5.27%
GateMacroTradfiHub·10-07 23:33
